Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fossati

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Cancer Research|December 1, 1986
Cancer procoagulant in human tumor cells: evidence from melanoma patientsM B Donati, C Gambacorti-Passerini, B Casali, et al.
Lupus|November 24, 2005
Lymphocyte subpopulations and intima media thickness in primary antiphospholipd syndromeP R J Ames, C Tommasino, G Fossati, et al.
FEMS Microbiology Immunology|December 1, 1992
Phagocyte activation in coronary artery diseaseG Ricevuti, A Mazzone, I Mazzucchelli, et al.
Lupus|February 24, 2001
Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot studyP R Ames, C Tommasino, J Alves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosisM Boccadoro, F Marmont, M Tribalto, et al.
Blood|September 1, 1988
Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease statusU Dianzani, A Pileri, M Boccadoro, et al.
The Journal of Biological Chemistry|November 3, 1995
Mycobacterium tuberculosis chaperonin 10 forms stable tetrameric and heptameric structures. Implications for its diverse biological activitiesG Fossati, P Lucietto, P Giuliani, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I studyA Balsari, R Marolda, C Gambacorti-Passerini, et al.
La Ricerca in Clinica E in Laboratorio|January 1, 1986
Adoptive immunotherapy of cancer with immune and activated lymphocytes: experimental and clinical studiesG Parmiani, M L Sensi, A Balsari, et al.
Oncogene|September 25, 2007
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cellsV Barbetti, A Gozzini, E Rovida, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Cancer Research|December 1, 1986
Cancer procoagulant in human tumor cells: evidence from melanoma patientsM B Donati, C Gambacorti-Passerini, B Casali, et al.
Lupus|November 24, 2005
Lymphocyte subpopulations and intima media thickness in primary antiphospholipd syndromeP R J Ames, C Tommasino, G Fossati, et al.
FEMS Microbiology Immunology|December 1, 1992
Phagocyte activation in coronary artery diseaseG Ricevuti, A Mazzone, I Mazzucchelli, et al.
Lupus|February 24, 2001
Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot studyP R Ames, C Tommasino, J Alves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosisM Boccadoro, F Marmont, M Tribalto, et al.
Blood|September 1, 1988
Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease statusU Dianzani, A Pileri, M Boccadoro, et al.
The Journal of Biological Chemistry|November 3, 1995
Mycobacterium tuberculosis chaperonin 10 forms stable tetrameric and heptameric structures. Implications for its diverse biological activitiesG Fossati, P Lucietto, P Giuliani, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I studyA Balsari, R Marolda, C Gambacorti-Passerini, et al.
La Ricerca in Clinica E in Laboratorio|January 1, 1986
Adoptive immunotherapy of cancer with immune and activated lymphocytes: experimental and clinical studiesG Parmiani, M L Sensi, A Balsari, et al.
Oncogene|September 25, 2007
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cellsV Barbetti, A Gozzini, E Rovida, et al.
Pageof 15